Know Cancer

or
forgot password

Specimen Banking From Patients With Lung Cancer


N/A
18 Years
85 Years
Open (Enrolling)
Both
Lung Neoplasms

Thank you

Trial Information

Specimen Banking From Patients With Lung Cancer


The aims of the study are as follows: 1) to continue to unravel the complex biology of lung
cancer 2) to identify early detection and prognostic markers to guide therapeutic decision
3) to define markers of response and/or resistance to drug therapy, and 4) to identify new
therapeutic and prevention targets.


Inclusion Criteria:



1. Subjects who are undergoing further testing for the diagnosis or treatment of lung
cancer.

2. Oral and written informed consent

Exclusion Criteria:

1. Any individual who does not give oral and written consent for participation

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

The primary objective of the protocol is to develop a comprehensive specimen banking program from patients with lung cancer for future translational research.

Outcome Description:

No statistical analysis will be applied to the overall collection of samples. Rather, each project that utilized tissue bank resources will require an appropriate statistical plan to be submitted along with the initial tissue request.

Outcome Time Frame:

6 years

Safety Issue:

No

Principal Investigator

Wilbur Franklin, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Colorado, Denver

Authority:

United States: Institutional Review Board

Study ID:

04-0688

NCT ID:

NCT01585675

Start Date:

November 2005

Completion Date:

May 2020

Related Keywords:

  • Lung Neoplasms
  • Lung Cancer
  • Neoplasms
  • Lung Neoplasms

Name

Location

University of Colorado Cancer CenterDenver, Colorado  80262